New Oral Anticoagulants: Comparative Pharmacology with Vitamin K Antagonists
New oral anticoagulants (OACs) that directly inhibit Factor Xa (FXa) or thrombin have been developed for the long-term prevention of thromboembolic disorders.
You may also like
Diagnostic Yield of Routine Daily Blood Culture in Patients on Veno-Arterial Extracorporeal Membrane Oxygenation
Although routine daily BCs are less effective than on-demand BCs and expose to contamination and inappropriate antimicrobial therapy, a policy restricted to on-demand BCs would omit a significant proportion of BSIs. This argues for a tailored approach to routine daily BCs on V-A ECMO, based on risk factors for positivity.
1 min read